Surface Oncology, Inc. Contracts & Agreements
43 Contracts & Agreements
- Business Finance (9 contracts)
- Business Operations (4)
- Human Resources (18)
- Intellectual Property (3)
- Mergers & Acquisitions (1)
- Real Estate (3)
- Uncategorized (5)
- Contingent Value Rights Agreement, dated as of September 8, 2023, by and among Coherus BioSciences, Inc., Computershare Inc. and Computershare Trust Company, N.A (Filed With SEC on September 8, 2023)
- Lease Termination Agreement, dated as of June 15, 2023, by and between BMR-Hampshire LLC and Surface Oncology, Inc (Filed With SEC on August 2, 2023)
- Agreement and Plan of Merger, by and among Surface Oncology, Inc., Coherus BioSciences, Inc., Crimson Merger Sub I, Inc. and Crimson Merger Sub II, LLC, dated June 15, 2023 (Form... (Filed With SEC on June 16, 2023)
- Form of Executive Agreement Amendment (Filed With SEC on June 16, 2023)
- Form of C-Suite Executive Agreement Amendment (Filed With SEC on June 16, 2023)
- Form of Retention Agreement (Filed With SEC on June 16, 2023)
- Second Amendment to Loan and Security Agreement, dated September 21, 2022, by and between Surface Oncology, Inc. and K2 HealthVentures LLC (Filed With SEC on September 23, 2022)
- 2021 Inducement Plan (Filed With SEC on March 2, 2022)
- Amendment No. 1, dated as of August 11, 2021, to License Agreement, dated as of December 16, 2020, by and between Surface Oncology, In.c and GLAXOSMITHKLINE INTELLECTUAL PROPERTY... (Filed With SEC on November 4, 2021)
- First Amendment to Loan and Security Agreement, dated October 1, 2021, by and among Surface Oncology, Inc. and, K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on October 4, 2021)
- Amendment No. 1, dated as of August 5, 2021, to Capital on DemandTM Sales Agreement, dated as of May 22, 2020, by and between Surface Oncology, Inc. and JonesTrading Institutional... (Filed With SEC on August 5, 2021)
- Exclusive Product License Agreement, dated March 23, 2021, by and between Vaccinex, Inc. and Surface Oncology, Inc (Filed With SEC on May 5, 2021)
- Amended and Restated Employment Agreement, dated April 26, 2021, by and between Jessica Fees and Surface Oncology, Inc (Filed With SEC on April 27, 2021)
- Amended and Restated Employment Agreement, dated February 9, 2020, by and between Robert Ross, M.D. and Surface Oncology, Inc (Filed With SEC on February 11, 2021)
- Transition and CEO Support Agreement, dated February 9, 2020, by and between J. Jeffrey Goater and Surface Oncology, Inc (Filed With SEC on February 11, 2021)
- License Agreement, dated as of December 16, 2020, by and between the Company and GLAXOSMITHKLINE INTELLECTUAL PROPERTY (No. 4) LIMITED (Filed With SEC on December 17, 2020)
- Capital on DemandTM Sales Agreement, dated as of May 22, 2020, by and between the Company and JonesTrading Institutional Services LLC (Filed With SEC on May 22, 2020)
- Sublease Agreement by and between the Company and EQRx, Inc., dated December 16, 2019 (Filed With SEC on March 10, 2020)
- Description of the Registrant's Securities (Filed With SEC on March 10, 2020)
- Loan and Security Agreement, dated November 22, 2019, by and among Surface Oncology, Inc. and, K2 HealthVentures LLC and Ankura Trust Company, LLC (Filed With SEC on November 25, 2019)
- Second Amendment to Lease, dated May 22, 2018, by and between BMR-Hampshire LLC and Surface Oncology, Inc (Filed With SEC on May 24, 2018)
- Contingent Employment Agreement Termination Letter between Daniel S. Lynch and the Registrant, dated March 30, 2018 (Filed With SEC on April 9, 2018)
- Form of Underwriting Agreement (Filed With SEC on March 30, 2018)
- Stock Purchase Agreement between the Registrant and Novartis Institutes for Biomedical Research, Inc., dated March 29, 2018 (Filed With SEC on March 30, 2018)
- Contingent Employment Agreement Termination Letter between Daniel S. Lynch and the Registrant, dated March 30, 2018 (Filed With SEC on March 30, 2018)
- Senior Executive Cash Incentive Bonus Plan (Filed With SEC on March 23, 2018)
- Separation Agreement between Detlev Biniszkiewicz, Ph.D. and the Registrant, dated September 27, 2017 (Filed With SEC on March 23, 2018)
- Employment Agreement between J. Jeffrey Goater and the Registrant (to be entered into in connection with this offering) (Filed With SEC on March 23, 2018)
- Employment Agreement between Daniel S. Lynch and the Registrant, dated November 23, 2016 (Filed With SEC on March 23, 2018)
- Employment Agreement between Robert W. Ross, M.D. and the Registrant (to be entered into in connection with this offering) (Filed With SEC on March 23, 2018)
- Employment Agreement between Vito J. Palombella, Ph.D. and the Registrant (to be entered into in connection with this offering) (Filed With SEC on March 23, 2018)
- Employment Agreement between Scott C. Chappel, Ph.D. and the Registrant (to be entered into in connection with this offering) (Filed With SEC on March 23, 2018)
- 2018 Employee Stock Purchase Plan (Filed With SEC on March 23, 2018)
- Form of Restricted Stock Unit Award Agreement for Non-Employee Directors under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- Form of Restricted Stock Unit Award Agreement for Company Employees under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- Form of Restricted Stock Award Agreement under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- Form of Non-Qualified Stock Option Agreement for Company Employees under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- Form of Incentive Stock Option Agreement under the Registrants 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- 2018 Stock Option and Incentive Plan (Filed With SEC on March 23, 2018)
- 2014 Stock Option and Grant Plan, as amended, and forms of award agreements thereunder (Filed With SEC on March 23, 2018)
- Amended and Restated Investors Rights Agreement among the Registrant and certain of its stockholders, dated November 6, 2014, as amended on January 9, 2016 (Filed With SEC on March 23, 2018)
- Specimen Common Stock Certificate (Filed With SEC on March 23, 2018)